meta-Hydroxynorephedrine

Meta-Hydroxynorephedrine
Clinical data
Other names	m-hydroxypropadrine; m-hydroxyphenylpropanolamine; α-methyl-m-octopamine; 3,β-dihydroxyamphetamine; 3,β-dihydroxy-α-methylphenethylamine
ATC code	None;
Legal status
Legal status	In general: non-regulated;
Identifiers
	IUPAC name 3-(2-amino-1-hydroxypropyl)phenol;
CAS Number	7619-17-2;
PubChem CID	4087;
ChemSpider	3945;
CompTox Dashboard (EPA)	DTXSID50858992 ;
Chemical and physical data
Formula	C9H13NO2
Molar mass	167.208 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES OC(c1cc(O)ccc1)C(N)C;
	InChI InChI=1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3; Key:WXFIGDLSSYIKKV-UHFFFAOYSA-N;

meta-Hydroxynorephedrine or 3-hydroxynorephedrine, also known as 3,β-dihydroxyamphetamine, is an adrenergic drug of the amphetamine class which was patented as a vasopressor and nasal decongestant but was never marketed.^[1]^[2] It is the racemic form of the sympathomimetic drug metaraminol.

References